Eve Medical is focused on reducing rates of cervical cancer by providing a user-friendly and resource-effective screening method.
Eve Medical has developed HerSwab, a device that enables women to self-collect samples to screen for cervical cancer, as well as other STIs. Cervical cancer is preventable with proper screening, yet more than 275,000 women die from it every year. By enabling women to collect their own sample, HerSwab can increase screening uptake and follow-up, and reduce mortality. This can improve patient outcomes and reduce costs for healthcare payers.